164 related articles for article (PubMed ID: 35865523)
1. Savior Siblings Might Rescue Fetal Lethality But Not Adult Lymphoma in Irf2bp2-Null Mice.
Vilmundarson RO; Heydarikhorneh N; Duong A; Ho T; Keyhanian K; Soheili F; Chen HH; Stewart AFR
Front Immunol; 2022; 13():868053. PubMed ID: 35865523
[TBL] [Abstract][Full Text] [Related]
2. IRF2BP2 Reduces Macrophage Inflammation and Susceptibility to Atherosclerosis.
Chen HH; Keyhanian K; Zhou X; Vilmundarson RO; Almontashiri NA; Cruz SA; Pandey NR; Lerma Yap N; Ho T; Stewart CA; Huang H; Hari A; Geoffrion M; McPherson R; Rayner KJ; Stewart AF
Circ Res; 2015 Sep; 117(8):671-83. PubMed ID: 26195219
[TBL] [Abstract][Full Text] [Related]
3. Control of Pathological Cardiac Hypertrophy by Transcriptional Corepressor IRF2BP2 (Interferon Regulatory Factor-2 Binding Protein 2).
Fang J; Li T; Zhu X; Deng KQ; Ji YX; Fang C; Zhang XJ; Guo JH; Zhang P; Li H; Wei X
Hypertension; 2017 Sep; 70(3):515-523. PubMed ID: 28716987
[TBL] [Abstract][Full Text] [Related]
4. IRF2BP2 is a skeletal and cardiac muscle-enriched ischemia-inducible activator of VEGFA expression.
Teng AC; Kuraitis D; Deeke SA; Ahmadi A; Dugan SG; Cheng BL; Crowson MG; Burgon PG; Suuronen EJ; Chen HH; Stewart AF
FASEB J; 2010 Dec; 24(12):4825-34. PubMed ID: 20702774
[TBL] [Abstract][Full Text] [Related]
5. Down-regulation of interferon regulatory factor 2 binding protein 2 suppresses gastric cancer progression by negatively regulating connective tissue growth factor.
Yao Y; Wang Y; Li L; Xiang X; Li J; Chen J; Liu Z; Huang S; Xiong J; Deng J
J Cell Mol Med; 2019 Dec; 23(12):8076-8089. PubMed ID: 31559693
[TBL] [Abstract][Full Text] [Related]
6. Hepatic IRF2BP2 Mitigates Nonalcoholic Fatty Liver Disease by Directly Repressing the Transcription of ATF3.
Fang J; Ji YX; Zhang P; Cheng L; Chen Y; Chen J; Su Y; Cheng X; Zhang Y; Li T; Zhu X; Zhang XJ; Wei X
Hepatology; 2020 May; 71(5):1592-1608. PubMed ID: 31529495
[TBL] [Abstract][Full Text] [Related]
7. Suppressing Irf2bp2 expressions accelerates metabolic syndrome-associated brain injury and hepatic dyslipidemia.
Ma YL; Xia JL; Gao X
Biochem Biophys Res Commun; 2018 Sep; 503(3):1651-1658. PubMed ID: 30131248
[TBL] [Abstract][Full Text] [Related]
8. Identification of a phosphorylation-dependent nuclear localization motif in interferon regulatory factor 2 binding protein 2.
Teng AC; Al-Montashiri NA; Cheng BL; Lou P; Ozmizrak P; Chen HH; Stewart AF
PLoS One; 2011; 6(8):e24100. PubMed ID: 21887377
[TBL] [Abstract][Full Text] [Related]
9. Fusion of the Genes for Interferon Regulatory Factor 2 Binding Protein 2 (
Panagopoulos I; Gorunova L; Lobmaier I; Heim S
In Vivo; 2023; 37(6):2459-2463. PubMed ID: 37905608
[TBL] [Abstract][Full Text] [Related]
10. IRF2BP2 transcriptional repressor restrains naive CD4 T cell activation and clonal expansion induced by TCR triggering.
Sécca C; Faget DV; Hanschke SC; Carneiro MS; Bonamino MH; de-Araujo-Souza PS; Viola JP
J Leukoc Biol; 2016 Nov; 100(5):1081-1091. PubMed ID: 27286791
[TBL] [Abstract][Full Text] [Related]
11. The novel p53 target gene IRF2BP2 participates in cell survival during the p53 stress response.
Koeppel M; van Heeringen SJ; Smeenk L; Navis AC; Janssen-Megens EM; Lohrum M
Nucleic Acids Res; 2009 Feb; 37(2):322-35. PubMed ID: 19042971
[TBL] [Abstract][Full Text] [Related]
12. The Tumor Suppressor Interferon Regulatory Factor 2 Binding Protein 2 Regulates Hippo Pathway in Liver Cancer by a Feedback Loop in Mice.
Feng X; Lu T; Li J; Yang R; Hu L; Ye Y; Mao F; He L; Xu J; Wang Z; Liu Y; Zhang Y; Ji H; Zhao Y; Cheng S; Tian W; Zhang L
Hepatology; 2020 Jun; 71(6):1988-2004. PubMed ID: 31538665
[TBL] [Abstract][Full Text] [Related]
13. IRF2BP2: A new player in the regulation of cell homeostasis.
Ramalho-Oliveira R; Oliveira-Vieira B; Viola JPB
J Leukoc Biol; 2019 Sep; 106(3):717-723. PubMed ID: 31022319
[TBL] [Abstract][Full Text] [Related]
14. IRF2BP2 modulates the crosstalk between glucocorticoid and TNF signaling.
Manjur ABMK; Lempiäinen JK; Malinen M; Palvimo JJ; Niskanen EA
J Steroid Biochem Mol Biol; 2019 Sep; 192():105382. PubMed ID: 31145973
[TBL] [Abstract][Full Text] [Related]
15. Novel frameshift variants expand the map of the genetic defects in IRF2BP2.
García-Aznar JM; Maneiro Pampín E; García Ramos M; Acuña Pérez MJ; Paz Gandiaga N; Minguell Domingo L; Calavia O; Soler-Palacin P; Colobran R; Novoa Bolívar EM; Ocejo Vinyals JG
Front Immunol; 2023; 14():1279171. PubMed ID: 37876937
[TBL] [Abstract][Full Text] [Related]
16. The Transcriptional Co-factor IRF2BP2: A New Player in Tumor Development and Microenvironment.
Pastor TP; Peixoto BC; Viola JPB
Front Cell Dev Biol; 2021; 9():655307. PubMed ID: 33996817
[TBL] [Abstract][Full Text] [Related]
17. IRF2BP2 is a novel HNF4α co-repressor: Its role in gluconeogenic gene regulation via biochemically labile interaction.
Kouketsu T; Monma R; Miyairi Y; Sawatsubashi S; Shima H; Igarashi K; Sugawara A; Yokoyama A
Biochem Biophys Res Commun; 2022 Jul; 615():81-87. PubMed ID: 35609419
[TBL] [Abstract][Full Text] [Related]
18. The NOTCH1-dependent HIF1α/VGLL4/IRF2BP2 oxygen sensing pathway triggers erythropoiesis terminal differentiation.
Wang Y; Liu X; Xie B; Yuan H; Zhang Y; Zhu J
Redox Biol; 2020 Jan; 28():101313. PubMed ID: 31539803
[TBL] [Abstract][Full Text] [Related]
19. Loss of IRF2BP2 in Microglia Increases Inflammation and Functional Deficits after Focal Ischemic Brain Injury.
Cruz SA; Hari A; Qin Z; Couture P; Huang H; Lagace DC; Stewart AFR; Chen HH
Front Cell Neurosci; 2017; 11():201. PubMed ID: 28769762
[TBL] [Abstract][Full Text] [Related]
20. Selective defects in the development of the fetal and adult lymphoid system in mice with an Ikaros null mutation.
Wang JH; Nichogiannopoulou A; Wu L; Sun L; Sharpe AH; Bigby M; Georgopoulos K
Immunity; 1996 Dec; 5(6):537-49. PubMed ID: 8986714
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
